Transcriptomic analysis has revealed that somatic inactivation mutations of the tumor suppressor gene TP53 and activation mutations of the proto-oncogene β-catenin (CTNNB1) are the most frequently observed mutations in ACC, these mutations have been associated with a poor prognosis in ACC patients (16). Here, TP53 is linked to adrenal cortex carcinoma.